Shares of Health Care sector company Series moved 0.8% today, and are now trading at a price of $72.19. The Large-Cap stock's daily volume was 260,562 compared to its average volume of 3,624,258. The S&P 500 index returned a 0.0% performance.
GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company is based in Chicago and has 53,000 full time employees. Its market capitalization is $32,959,211,520. Series currently offers its equity investors a dividend that yields 0.1% per year.
20 analysts are following Series and have set target prices ranging from $73.0 to $106.0 per share. On average, they have given the company a rating of buy. At today's prices, GEHC is trading -17.26% away from its average analyst target price of $87.25 per share.
Over the last year, GEHC shares have gone down by -18.2%, which represents a difference of -34.4% when compared to the S&P 500. The stock's 52 week high is $94.8 per share and its 52 week low is $57.65. Although Series's average free cash flow over the last 3 years has been $1.15 Billion, they have been decreasing at an average rate of -33.1%. For this reason, investors may continue to shun the stock.
| Date Reported | Cash Flow from Operations ($ k) | Capital expenditures ($ k) | Free Cash Flow ($ k) | YoY Growth (%) |
|---|---|---|---|---|
| 2024 | 913,000 | 401,000 | 512,000 | -22.78 |
| 2023 | 1,050,000 | 387,000 | 663,000 | -67.77 |
| 2022 | 2,134,000 | 77,000 | 2,057,000 | 51.36 |
| 2021 | 1,607,000 | 248,000 | 1,359,000 |
